Impact of ursodeoxycholic acid therapy in autoimmune liver disease patients with COVID-19 and its clinical prognosis
To explore the impact of ursodeoxycholic acid (UDCA) on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and clinical outcomes in patients with autoimmune liver disease (AILD). Patients diagnosed with AILD were enrolled and divided into a UDCA group and a non-UDCA group based o...
Saved in:
Main Authors: | Minghui Li (Author), Weihua Cao (Author), Tingting Jiang (Author), Wen Deng (Author), Shiyu Wang (Author), Shuling Wu (Author), Lu Zhang (Author), Yao Lu (Author), Min Chang (Author), Ruyu Liu (Author), Xiaoyan Ding (Author), Ge Shen (Author), Yuanjiao Gao (Author), Hongxiao Hao (Author), Xiaoxue Chen (Author), Leiping Hu (Author), Mengjiao Xu (Author), Yuyong Jiang (Author), Wei Yi (Author), Yao Xie (Author), Rui Song (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016) -
STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016) -
High-fat diets enhance and delay ursodeoxycholic acid absorption but elevate circulating hydrophobic bile salts
by: Liang Huang, et al.
Published: (2023) -
Ursodeoxycholic acid in neonatal sepsis-associated cholestasis
by: Rita Mey Rina, et al.
Published: (2014) -
Use of Ursodeoxycholic Acid for the Treatment of Biliary Dysfunction in Children
by: T.V. Yaroshevskaya, et al.
Published: (2013)